Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,237 | -8,619 | 1,965 | -13,562 | 6,256 |
| Depreciation Amortization | 2,894 | 1,746 | 832 | 5,485 | 3,995 |
| Accounts receivable | 6,666 | 232 | -2,070 | -7,629 | -12,299 |
| Accounts payable and accrued liabilities | -387 | 658 | 1,741 | 287 | 1,727 |
| Other Working Capital | 2,146 | 3,960 | -23 | -5,733 | -7,374 |
| Other Operating Activity | 1,793 | 5,080 | -3,063 | 19,215 | 2,955 |
| Operating Cash Flow | $-1,125 | $3,057 | $-618 | $-1,937 | $-4,740 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -17 | -17 | N/A | 440 | 457 |
| Net Acquisitions | N/A | N/A | N/A | -3,000 | N/A |
| Investing Cash Flow | $-17 | $-17 | $N/A | $-2,560 | $457 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,348 | 12 | 5,810 | 6,668 | 7,633 |
| Debt Issued | N/A | N/A | N/A | 1,857 | N/A |
| Debt Repayment | -4,443 | -3,979 | -3,514 | -7,873 | -5,183 |
| Common Stock Issued | N/A | N/A | N/A | 14,840 | N/A |
| Other Financing Activity | 0 | 0 | 0 | -49 | 0 |
| Financing Cash Flow | $-3,095 | $-3,967 | $2,296 | $15,443 | $2,450 |
| Beginning Cash Position | 30,952 | 30,952 | 30,952 | 20,006 | 20,006 |
| End Cash Position | 26,715 | 30,025 | 32,630 | 30,952 | 18,173 |
| Net Cash Flow | $-4,237 | $-927 | $1,678 | $10,946 | $-1,833 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,125 | 3,057 | -618 | -1,937 | -4,740 |
| Capital Expenditure | -17 | -17 | N/A | -228 | -211 |
| Free Cash Flow | -1,142 | 3,040 | -618 | -2,165 | -4,951 |